These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 28062946

  • 1. Upregulated absorption of dietary palmitic acids with changes in intestinal transporters in non-alcoholic steatohepatitis (NASH).
    Utsunomiya H, Yamamoto Y, Takeshita E, Tokumoto Y, Tada F, Miyake T, Hirooka M, Abe M, Kumagi T, Matsuura B, Ikeda Y, Hiasa Y.
    J Gastroenterol; 2017 Aug; 52(8):940-954. PubMed ID: 28062946
    [Abstract] [Full Text] [Related]

  • 2. Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients.
    Enooku K, Tsutsumi T, Kondo M, Fujiwara N, Sasako T, Shibahara J, Kado A, Okushin K, Fujinaga H, Nakagomi R, Minami T, Sato M, Uchino K, Nakagawa H, Kondo Y, Asaoka Y, Tateishi R, Ueki K, Ikeda H, Yoshida H, Moriya K, Yotsuyanagi H, Kadowaki T, Koike K.
    J Gastroenterol; 2020 Feb; 55(2):227-243. PubMed ID: 31602526
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rapid alternative absorption of dietary long-chain fatty acids with upregulation of intestinal glycosylated CD36 in liver cirrhosis.
    Yamamoto Y, Hiasa Y, Murakami H, Ikeda Y, Yamanishi H, Abe M, Matsuura B, Onji M.
    Am J Clin Nutr; 2012 Jul; 96(1):90-101. PubMed ID: 22648712
    [Abstract] [Full Text] [Related]

  • 6. The mechanism of increased intestinal palmitic acid absorption and its impact on hepatic stellate cell activation in nonalcoholic steatohepatitis.
    Hanayama M, Yamamoto Y, Utsunomiya H, Yoshida O, Liu S, Mogi M, Matsuura B, Takeshita E, Ikeda Y, Hiasa Y.
    Sci Rep; 2021 Jun 28; 11(1):13380. PubMed ID: 34183709
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis.
    Chatterjee A, Basu A, Das K, Singh P, Mondal D, Bhattacharya B, Roychoudhury S, Majumder PP, Chowdhury A, Basu P.
    Ann Hepatol; 2020 Jun 28; 19(5):472-481. PubMed ID: 32682086
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Development and physiological regulation of intestinal lipid absorption. I. Development of intestinal lipid absorption: cellular events in chylomicron assembly and secretion.
    Black DD.
    Am J Physiol Gastrointest Liver Physiol; 2007 Sep 28; 293(3):G519-24. PubMed ID: 17495031
    [Abstract] [Full Text] [Related]

  • 15. Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver disease.
    Wada N, Takaki A, Ikeda F, Yasunaka T, Onji M, Nouso K, Nakatsuka A, Wada J, Koike K, Miyahara K, Shiraha H, Yamamoto K, Okada H.
    Hepatol Int; 2017 Jan 28; 11(1):115-124. PubMed ID: 27826704
    [Abstract] [Full Text] [Related]

  • 16. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.
    Bellanti F, Villani R, Facciorusso A, Vendemiale G, Serviddio G.
    Free Radic Biol Med; 2017 Oct 28; 111():173-185. PubMed ID: 28109892
    [Abstract] [Full Text] [Related]

  • 17. Non-Alcoholic Fatty Liver Disease.
    Engin A.
    Adv Exp Med Biol; 2017 Oct 28; 960():443-467. PubMed ID: 28585211
    [Abstract] [Full Text] [Related]

  • 18. O-GlcNAcylation promotes the progression of nonalcoholic fatty liver disease by upregulating the expression and function of CD36.
    Zhu H, Zhao T, Zhao S, Yang S, Jiang K, Li S, Kang Y, Yang Z, Shen J, Shen S, Tao H, Xuan J, Yang M, Xu B, Wang F, Jiang M.
    Metabolism; 2024 Jul 28; 156():155914. PubMed ID: 38642829
    [Abstract] [Full Text] [Related]

  • 19. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
    Simon Y, Kessler SM, Gemperlein K, Bohle RM, Müller R, Haybaeck J, Kiemer AK.
    World J Gastroenterol; 2014 Dec 21; 20(47):17839-50. PubMed ID: 25548482
    [Abstract] [Full Text] [Related]

  • 20. Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model.
    Nozaki Y, Fujita K, Wada K, Yoneda M, Kessoku T, Shinohara Y, Imajo K, Ogawa Y, Nakamuta M, Saito S, Masaki N, Nagashima Y, Terauchi Y, Nakajima A.
    BMC Gastroenterol; 2015 Apr 01; 15():42. PubMed ID: 25881230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.